
ACACB - Wikipedia
Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin -containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate …
ACACB Gene - GeneCards | ACACB Protein | ACACB Antibody
Dec 24, 2024 · ACACB (Acetyl-CoA Carboxylase Beta) is a Protein Coding gene. Diseases associated with ACACB include Bardet-Biedl Syndrome 18 and Leukoencephalopathy, …
ACACB is a novel metabolism-related biomarker in the prediction …
ACACB is a biomarker for CTX therapy in metastatic CRC. Cetuximab is one of the most valuable targeted therapy monoclonal antibodies in the treatment of metastatic colorectal cancer …
The Effect of ACACB cis-Variants on Gene Expression and …
We sought to determine whether ACACB transcribed variants were associated with ACACB gene expression and insulin sensitivity in non-diabetic African American (AA) and European …
B1a B cells require autophagy for metabolic homeostasis and self ...
Autophagy is differentially activated in B1a B cells, and deletion of the autophagy gene Atg7 leads to a selective loss of B1a B cells caused by a failure of self-renewal. Autophagy-deficient B1a …
ACACB acetyl-CoA carboxylase beta - NIH Genetic Testing …
Jun 9, 2024 · Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, …
ACACB acetyl-CoA carboxylase beta [ Homo sapiens (human) ]
Jan 4, 2025 · Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, …
Fatty acid synthesis and cancer: Aberrant expression of the
Dec 1, 2020 · Altered lipid metabolism is a characteristic feature of cancer cells. This systematic review assesses the risk for cancer development in association with the expression levels of …
ACACB is a novel metabolism-related biomarker in the ... - PubMed
Sep 25, 2022 · We find that acetyl-CoA carboxylase beta (ACACB), ADH1C, CES1, MGLL, FMO5, and GPT are the hub DEGs, and ACACB is the most important biomarker among them.
Inhibition of acetyl-CoA carboxylase suppresses fatty acid …
Continuous de novo fatty acid synthesis is a common feature of cancer that is required to meet the biosynthetic demands of a growing tumor. This process is controlled by the rate-limiting …